Rechon Life Science AB is a subsidiary/entity within the Recipharm group, the global CDMO headquartered in Stockholm, Sweden. This entry represents the same Recipharm organization (same website: recipharm.com) with its extensive global manufacturing footprint of 15+ FDA-registered FEI numbers and 52 FDA inspections. The Perplexity research confirms Recipharm's specialization in oral solid dose, inhalation, sterile manufacturing, and HPAPI capabilities. Rechon may represent a specific Recipharm site or legacy entity. Duplicate of Recipharm AB entry -- capabilities are identical.
oral solid dose manufacturing, sterile fill/finish, HPAPI manufacturing, advanced therapies (xRNA, viral vectors, microbiome), drug delivery device design, inhalation products, European manufacturing backbone
11 sites worldwide
No reviews available yet.
No documents available.